These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

647 related articles for article (PubMed ID: 25673984)

  • 21. Oxidative stress in COPD.
    Kirkham PA; Barnes PJ
    Chest; 2013 Jul; 144(1):266-273. PubMed ID: 23880677
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diet and obstructive lung diseases.
    Romieu I; Trenga C
    Epidemiol Rev; 2001; 23(2):268-87. PubMed ID: 12192737
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oxidative stress and gene transcription in asthma and chronic obstructive pulmonary disease: antioxidant therapeutic targets.
    Rahman I
    Curr Drug Targets Inflamm Allergy; 2002 Sep; 1(3):291-315. PubMed ID: 14561194
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel aspects of pathogenesis and regeneration mechanisms in COPD.
    Bagdonas E; Raudoniute J; Bruzauskaite I; Aldonyte R
    Int J Chron Obstruct Pulmon Dis; 2015; 10():995-1013. PubMed ID: 26082624
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oxidants and antioxidants as therapeutic targets in chronic obstructive pulmonary disease.
    Macnee W; Rahman I
    Am J Respir Crit Care Med; 1999 Nov; 160(5 Pt 2):S58-65. PubMed ID: 10556172
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oxidative stress and antioxidant enzyme activity in South Indian male smokers with chronic obstructive pulmonary disease.
    Arja C; Surapaneni KM; Raya P; Adimoolam C; Balisetty B; Kanala KR
    Respirology; 2013 Oct; 18(7):1069-75. PubMed ID: 23683270
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effects of smoking on the pathogenesis of COPD].
    Tatsumi K
    Nihon Rinsho; 2007 Apr; 65(4):605-10. PubMed ID: 17419375
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decline in NRF2-regulated antioxidants in chronic obstructive pulmonary disease lungs due to loss of its positive regulator, DJ-1.
    Malhotra D; Thimmulappa R; Navas-Acien A; Sandford A; Elliott M; Singh A; Chen L; Zhuang X; Hogg J; Pare P; Tuder RM; Biswal S
    Am J Respir Crit Care Med; 2008 Sep; 178(6):592-604. PubMed ID: 18556627
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oxidative stress and respiratory system: pharmacological and clinical reappraisal of N-acetylcysteine.
    Santus P; Corsico A; Solidoro P; Braido F; Di Marco F; Scichilone N
    COPD; 2014 Dec; 11(6):705-17. PubMed ID: 24787454
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Decreased expression of antioxidant enzymes and increased expression of chemokines in COPD lung.
    Tomaki M; Sugiura H; Koarai A; Komaki Y; Akita T; Matsumoto T; Nakanishi A; Ogawa H; Hattori T; Ichinose M
    Pulm Pharmacol Ther; 2007; 20(5):596-605. PubMed ID: 16919984
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of oxidative stress in the pathogenesis of COPD.
    Nucera F; Mumby S; Paudel KR; Dharwal V; DI Stefano A; Casolaro V; Hansbro PM; Adcock IM; Caramori G
    Minerva Med; 2022 Jun; 113(3):370-404. PubMed ID: 35142479
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Update in chronic obstructive pulmonary disease: role of antioxidant and metabolizing gene polymorphisms.
    Lakhdar R; Denden S; Kassab A; Leban N; Knani J; Lefranc G; Miled A; Chibani JB; Khelil AH
    Exp Lung Res; 2011 Aug; 37(6):364-75. PubMed ID: 21721950
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antioxidant pharmacological therapies for COPD.
    Rahman I; MacNee W
    Curr Opin Pharmacol; 2012 Jun; 12(3):256-65. PubMed ID: 22349417
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Markers of anti-oxidant response in tobacco smoke exposed subjects: a data-mining review.
    Comandini A; Marzano V; Curradi G; Federici G; Urbani A; Saltini C
    Pulm Pharmacol Ther; 2010 Dec; 23(6):482-92. PubMed ID: 20594977
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 1. COPD pathogenesis from the viewpoint of risk factors.
    Teramoto S
    Intern Med; 2007; 46(2):77-9. PubMed ID: 17220602
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oxidative stress-induced mitochondrial dysfunction drives inflammation and airway smooth muscle remodeling in patients with chronic obstructive pulmonary disease.
    Wiegman CH; Michaeloudes C; Haji G; Narang P; Clarke CJ; Russell KE; Bao W; Pavlidis S; Barnes PJ; Kanerva J; Bittner A; Rao N; Murphy MP; Kirkham PA; Chung KF; Adcock IM;
    J Allergy Clin Immunol; 2015 Sep; 136(3):769-80. PubMed ID: 25828268
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic Potential of Small Molecules Targeting Oxidative Stress in the Treatment of Chronic Obstructive Pulmonary Disease (COPD): A Comprehensive Review.
    Dailah HG
    Molecules; 2022 Aug; 27(17):. PubMed ID: 36080309
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New frontiers in the treatment of comorbid cardiovascular disease in chronic obstructive pulmonary disease.
    Brassington K; Selemidis S; Bozinovski S; Vlahos R
    Clin Sci (Lond); 2019 Apr; 133(7):885-904. PubMed ID: 30979844
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oxidant metabolism in chronic obstructive pulmonary disease.
    Boots AW; Haenen GR; Bast A
    Eur Respir J Suppl; 2003 Nov; 46():14s-27s. PubMed ID: 14621103
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antioxidants and mucolytics in COPD management: when (if ever) and in whom?
    Hillas G; Nikolakopoulou S; Hussain S; Vassilakopoulos T
    Curr Drug Targets; 2013 Feb; 14(2):225-34. PubMed ID: 23256719
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.